☆ 4.7 Article

A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation

EBIOMEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Engineering, Biomedical

A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody

Zhilin Li et al.

Summary: To improve the response rate of immune checkpoint inhibitors in immunosuppressive cancers, a self-amplified biomimetic nanosystem was constructed to induce immunogenic cell death at tumor sites. The nanosystem effectively reverses the immunosuppressive tumor microenvironment, leading to distinctive inhibition of tumor growth and metastasis when combined with immune checkpoint inhibitors.

BIOACTIVE MATERIALS (2023)

添加到收藏夹

Review Chemistry, Multidisciplinary

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Zhilin Li et al.

Summary: This article reviews the use of nanostructure-based drug delivery systems (NDDSs) to enhance the effectiveness of tumor immunotherapy. By inducing immunogenic cell death (ICD) and releasing danger-associated molecular patterns (DAMPs) and tumor-associated antigens, in combination with chemotherapy, photodynamic therapy, photothermal therapy, and radiotherapy, the tumor immunosuppressive microenvironment can be improved, resulting in increased sensitivity to immunotherapy and reduced side effects.

ADVANCED SCIENCE (2022)

添加到收藏夹

Review Oncology

Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma

Muhammed H. Elnaggar et al.

Summary: The use of nanoparticles as targeted carriers for chemotherapy in hepatocellular carcinoma has shown promising results, with active targeting being the most commonly researched method. However, clinical research still faces challenges such as batch variations, production limitations, and lack of toxicity data.

SEMINARS IN CANCER BIOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Nanoparticle Toxicology

Wen Yang et al.

Summary: This article reviews the potential adverse effects of nanoparticles on human health and discusses mechanisms of nanotoxicity, including the generation of reactive oxygen species, nanoparticle disintegration, and modulation of cell signaling pathways. Improved understanding of nanoparticle toxicity may lead to strategies for safe application of nanotechnology.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)

添加到收藏夹

Review Nanoscience & Nanotechnology

Organ-specific toxicity of magnetic iron oxide-based nanoparticles

Vladimir V. Chrishtop et al.

Summary: The unique properties of magnetic iron oxide nanoparticles make them widely used in various industries, but research on their chronic nanotoxicology is insufficient. Toxicity may vary depending on the route of administration, and specific effects can be seen through the sensory nerve pathway. Attention should be paid to potential toxic effects on different organ systems and the reproductive system.

NANOTOXICOLOGY (2021)

添加到收藏夹

Article Engineering, Biomedical

Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies

Yuchen Wang et al.

Summary: A novel nanoparticle drug delivery system targeting colorectal cancer was developed in this study, which significantly improved the efficacy of the drug compared to current standard treatments. The nanoparticles increased the intratumoral concentration of the therapeutic agent, leading to reduced side effects during treatment.

BIOMATERIALS (2021)

添加到收藏夹

Article Surgery

Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection

Ke Zhou et al.

Summary: Organ transplantation is a common therapy for end-stage organ diseases, but long-term immunosuppressive agent use can lead to side effects and complications. By modifying compounds into nanoparticles, researchers have developed a new therapeutic approach to reduce immune response and improve graft survival in organ transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Early liver transplantation for acute alcoholic hepatitis: We can't say no

Philippe Mathurin

Summary: For severe alcoholic hepatitis patients not responding to medical therapy, postponing the decision to list for transplantation is harmful as there are no other therapeutic alternatives available. Early transplantation, with a strict selection process, has gained increasing support from experts globally, but there is still significant heterogeneity in its application across countries and even within the same country.

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Sirolimus in renal transplant recipients with malignancies in Germany

Marcel G. Naik et al.

Summary: The study retrospectively analyzed 726 renal transplant recipients converted to sirolimus, showing lower cancer incidence rates after conversion. Patients with prior malignancy were older but had lower cancer rates after conversion. Renal function and graft survival were better in all cancer types compared to patients converted to sirolimus without cancers. Patient survival was largely dependent on tumor entity.

CLINICAL KIDNEY JOURNAL (2021)

添加到收藏夹

Review Surgery

Liver transplantation for hepatocellular carcinoma: Management after the transplant

Elizabeth C. Verna et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

添加到收藏夹

Review Immunology

mTOR signaling at the crossroads of environmental signals and T-cell fate decisions

Hongling Huang et al.

IMMUNOLOGICAL REVIEWS (2020)

添加到收藏夹

Article Engineering, Biomedical

Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance

Mengran Xu et al.

BIOMATERIALS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation

Mei-Xi Wang et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)

添加到收藏夹

Article Surgery

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Andreas A. Schnitzbauer et al.

ANNALS OF SURGERY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival

Haiyang Xie et al.

JOURNAL OF CONTROLLED RELEASE (2020)

添加到收藏夹

Article Immunology

Delayed allogeneic skin graft rejection in CD26-deficient mice

Xiangli Zhao et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Feedback Activation of SGK3 and AKT Contributes to Rapamycin Resistance by Reactivating mTORC1/4EBP1 Axis via TSC2 in Breast Cancer

Hongtao Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

添加到收藏夹

Review Immunology

Cancer and mTOR Inhibitors in Transplant Recipients

Johan W. de Fijter

TRANSPLANTATION (2018)

添加到收藏夹

Article Immunology

Etiology of increased cancer incidence after solid organ transplantation

Sergio A. Acuna

TRANSPLANTATION REVIEWS (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

Gonzalo Sapisochin et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Review Immunology

Cancer recurrence after solid organ transplantation: A systematic review and meta-analysis

Sergio A. Acuna et al.

TRANSPLANTATION REVIEWS (2017)

添加到收藏夹

Article Oncology

New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity

Hangxiang Wang et al.

CANCER RESEARCH (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Nanoformulations for combination or cascade anticancer therapy

Lei Miao et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

添加到收藏夹

Review Immunology

Cancer and mTOR Inhibitors in Transplant Recipients

Johan W. de Fijter

TRANSPLANTATION (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Effects of Maintenance Immunosuppression With Sirolimus After Liver Transplant for Hepatocellular Carcinoma

Elizabeth L. Yanik et al.

LIVER TRANSPLANTATION (2016)

添加到收藏夹

Article Immunology

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Edward K. Geissler et al.

TRANSPLANTATION (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma: a systematic review and a meta-analysis

Hua-Shan Lin et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Marina A. Dobrovolskaia

JOURNAL OF CONTROLLED RELEASE (2015)

添加到收藏夹

News Item Urology & Nephrology

DECADE IN REVIEW-RENAL TRANSPLANTATION A spectrum of advances in renal transplantation

Bruce Kaplan

NATURE REVIEWS NEPHROLOGY (2015)

添加到收藏夹

Article Oncology

Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells

Wei Chen et al.

CANCER BIOLOGY & THERAPY (2014)

添加到收藏夹

Review Cell Biology

Rapamycin: One Drug, Many Effects

Jing Li et al.

CELL METABOLISM (2014)

添加到收藏夹

Article Oncology

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

Padhma Radhakrishnan et al.

CANCER RESEARCH (2013)

添加到收藏夹

Review Immunology

mTOR and lymphocyte metabolism

Hu Zeng et al.

CURRENT OPINION IN IMMUNOLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

Manuel Rodriguez-Peralvarez et al.

JOURNAL OF HEPATOLOGY (2013)

添加到收藏夹

Review Gastroenterology & Hepatology

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

Michael R. Lucey et al.

LIVER TRANSPLANTATION (2013)

添加到收藏夹

Article Immunology

Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History

Christina Brattstrom et al.

TRANSPLANTATION (2013)

添加到收藏夹

Article Oncology

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric-Bernstam et al.

CLINICAL CANCER RESEARCH (2012)

添加到收藏夹

Article Medicine, General & Internal

Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

Sylvie Euvrard et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Oncology

Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling

Xin He et al.

CANCER LETTERS (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma

Christian Toso et al.

HEPATOLOGY (2010)

添加到收藏夹

Review Gastroenterology & Hepatology

Prioritization for liver transplantation

Evangelos Cholongitas et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

添加到收藏夹

Article Hematology

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

Mamta Gupta et al.

BLOOD (2009)

添加到收藏夹

Article Oncology

Inhibition of Akt signaling by SN-38 induces apoptosis in cervical cancer

Youqing Liu et al.

CANCER LETTERS (2009)

添加到收藏夹

Article Oncology

Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma

C. -B. Hsieh et al.

EJSO (2008)

添加到收藏夹

Review Pharmacology & Pharmacy

Rapamycin: Something old, something new, sometimes borrowed and now renewed

C. M. Hartford et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

X. Wan et al.

ONCOGENE (2007)

添加到收藏夹

Article Immunology

mTOR inhibition and its effect on cancer in transplantation

J Andrassy et al.

TRANSPLANTATION (2005)

添加到收藏夹

Article Oncology

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition

SY Sun et al.

CANCER RESEARCH (2005)

添加到收藏夹

Article Immunology

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

GE Koehl et al.

TRANSPLANTATION (2004)

添加到收藏夹

Article Biochemistry & Molecular Biology

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

M Guba et al.

NATURE MEDICINE (2002)

添加到收藏夹

Article Hematology

Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival

J Gonzalez et al.

BLOOD CELLS MOLECULES AND DISEASES (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.